ArticleJournal of perinatology : official journal of the California Perinatal Association2026
Current practices in the management of hemodynamically significant patent ductus arteriosus.
Article in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo describe current practices among neonatologists and cardiologists regarding the diagnosis and management of hemodynamically significant patent ductus arteriosus (hsPDA) in premature infants, with particular focus on the valuation of echocardiographic parameters, use of scoring systems, and availability of treatment modalities. STUDY
designCross-sectional survey of members of the American Academy of Pediatrics Sections on Neonatal-Perinatal Medicine and Cardiology and Cardiac Surgery, and the Pediheart.net community, regarding approaches to diagnosing and treating hsPDA.
result422 providers participated. Only 13.5% recommended routine screening echocardiography. Formal scoring systems were rarely used. Agreement on echocardiographic parameter importance was seen in only two of the nine parameters. Reported treatment availability included medical therapy (99%), surgical ligation (74%), and catheter closure (66%). Catheter closure was more frequently preferred than surgical ligation. Of respondents, 315 were neonatologists (estimated response rate 7% of SONPM), and 107 were cardiologists (estimated response rate 5.4% of SOCCS/Pediheart, noting significant membership overlap between these groups).
conclusionSubstantial differences exist between neonatologists and cardiologists in the perceived value of echocardiographic markers for hsPDA. Formal scoring systems are infrequently used with wide variation in adoption, and catheter-based occlusion has been rapidly adopted. Greater consensus in PDA assessment and management is needed.
Identifiers
42806044What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.